These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 19579700

  • 21. [Study of acute vulvovaginitis in sexually active adult women, with special reference to candidosis, in patients of the Francisco J. Muñiz Infectious Diseases Hospital].
    Buscemi L, Arechavala A, Negroni R.
    Rev Iberoam Micol; 2004 Dec; 21(4):177-81. PubMed ID: 15709796
    [Abstract] [Full Text] [Related]

  • 22. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy.
    Shahid Z, Sobel JD.
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):354-6. PubMed ID: 19501794
    [Abstract] [Full Text] [Related]

  • 23. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L, Dudiuk C, Morano S, Gamarra S, Nardin ME, Méndez E, Garcia-Effron G.
    Rev Argent Microbiol; 2016 Dec; 48(1):43-9. PubMed ID: 26922471
    [Abstract] [Full Text] [Related]

  • 25. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia.
    Sojakova M, Liptajova D, Borovsky M, Subik J.
    Mycopathologia; 2004 Feb; 157(2):163-9. PubMed ID: 15119851
    [Abstract] [Full Text] [Related]

  • 26. [Identification by PCR and antifungal susceptibility of vaginal clinical Candida sp isolates].
    Alves IA, Camargo FP, Goulart LS.
    Rev Soc Bras Med Trop; 2010 Feb; 43(5):575-9. PubMed ID: 21085873
    [Abstract] [Full Text] [Related]

  • 27. Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis.
    Vazquez JA, Peng G, Sobel JD, Steele-Moore L, Schuman P, Holloway W, Neaton JD.
    Clin Infect Dis; 2001 Oct 01; 33(7):1069-75. PubMed ID: 11528582
    [Abstract] [Full Text] [Related]

  • 28. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR, Liu XP, Li JW.
    J Obstet Gynaecol Res; 2008 Aug 01; 34(4):561-6. PubMed ID: 18937710
    [Abstract] [Full Text] [Related]

  • 29. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis.
    Fan SR, Liu XP.
    Mycoses; 2011 Nov 01; 54(6):501-5. PubMed ID: 20406393
    [Abstract] [Full Text] [Related]

  • 30. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME, Podda GS, Pisano MB, Deplano M, Cosentino S.
    J Prev Med Hyg; 2008 Jun 01; 49(2):69-74. PubMed ID: 18847180
    [Abstract] [Full Text] [Related]

  • 31. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
    Linares MJ, Charriel G, Solís F, Casal M.
    Enferm Infecc Microbiol Clin; 2003 Nov 01; 21(9):493-7. PubMed ID: 14572382
    [Abstract] [Full Text] [Related]

  • 32. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin].
    Diaz MC, Camponovo R, Araya I, Cerda A, Santander MP, Carrillo-Muñoz AJ.
    Rev Esp Quimioter; 2016 Jun 01; 29(3):151-4. PubMed ID: 27167765
    [Abstract] [Full Text] [Related]

  • 33. Voriconazole activity against clinical yeast isolates: a multicentre Italian study.
    Morace G, Polonelli L, GISIA Group.
    Int J Antimicrob Agents; 2005 Sep 01; 26(3):247-53. PubMed ID: 16051469
    [Abstract] [Full Text] [Related]

  • 34. [Results of antifungal susceptibility testing of Candida species and trends of antifungal use in Niigata university medical and dental hospital].
    Aoki T, Moro H, Koshio N, Tamura T, Tanabe Y, Kawai H, Matsuto T, Okada M.
    Rinsho Byori; 2010 Jul 01; 58(7):658-63. PubMed ID: 20715508
    [Abstract] [Full Text] [Related]

  • 35. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens.
    Marangon FB, Miller D, Giaconi JA, Alfonso EC.
    Am J Ophthalmol; 2004 May 01; 137(5):820-5. PubMed ID: 15126145
    [Abstract] [Full Text] [Related]

  • 36. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A, Torres HA, Lewis RE, Thornby J, Bodey GP, Tarrand JP, Han XY, Rolston KV, Safdar A, Raad II, Kontoyiannis DP.
    Medicine (Baltimore); 2003 Sep 01; 82(5):309-21. PubMed ID: 14530780
    [Abstract] [Full Text] [Related]

  • 37. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
    Testore GP, Dori L, Buonomini AR, Schito GC, Soro O, Fortina G, Andreoni S, Carlone N, Tullio V, Andreoni M.
    Diagn Microbiol Infect Dis; 2004 Nov 01; 50(3):187-92. PubMed ID: 15541604
    [Abstract] [Full Text] [Related]

  • 38. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.
    Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Dzierzanowska D, Ellis D, Finquelievich J, Gould I, Gur D, Hoosen A, Lee K, Mallatova N, Mallie M, Peng NG, Petrikos G, Santiago A, Trupl J, VanDen Abeele AM, Wadula J, Zaidi M, Global Antifungal Surveillance Group.
    Diagn Microbiol Infect Dis; 2010 Jun 01; 67(2):162-71. PubMed ID: 20338711
    [Abstract] [Full Text] [Related]

  • 39. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV, Krysenko AV, Sirokvasha EA, Vinnikov AI.
    Mikrobiol Z; 2007 Jun 01; 69(3):57-62. PubMed ID: 17682532
    [Abstract] [Full Text] [Related]

  • 40. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M, Kunz L, Rüchel R, Reichard U, Weig M, Gross U.
    J Antimicrob Chemother; 2007 Aug 01; 60(2):424-8. PubMed ID: 17562683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.